CompanyGraph
What stands out
- Valued far above the size of its business
At a glance
- Depends onMidstream position: 5 outgoing, 4 incoming connections
- FinancialsAltman Z-Score 13.29: safe zone
- Interpretations1 currently firing — 1
Sign in to view price data.
Sign inThe reported statements, read against the company's own industry.
What stands out
- Valued far above the size of its business
Financials view
Market Capitalization
3.84BCNY569.71M · vs all stocks (USD)
Revenue (TTM)
253.87MCNY37.70M · vs all stocks (USD)
Profit Margin
-3.73%Beta
0.4790xvs all stocks
52-Week Change
-24.37%vs all stocks
Market Capitalization
3.84BCNY569.71M · vs all stocks (USD)
Enterprise Value
3.63BCNY538.76M · vs all stocks (USD)
Price to Sales (TTM)
15.72xPrice to Book (MRQ)
5.89xEnterprise to Revenue
14.29xGross Margin
24.24%Profit Margin
-3.73%Operating Margin
-9.33%Return on Assets (TTM)
-0.85%Return on Equity (TTM)
-1.02%Revenue (TTM)
253.87MCNY37.70M · vs all stocks (USD)
Revenue per Share (TTM)
0.1970CNYUpdated Aug 19, 2026Quarterly Revenue Growth
-24.50%Gross Profit (TTM)
54.39MCNY8.08M · vs all stocks (USD)
EBITDA (TTM)
8.76MCNY1.30M · vs all stocks (USD)
Net Income (TTM)
-9.47MCNY-1.41M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
-47.23%Operating Cash Flow (TTM)
-33.48MCNY-4.97M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
-88.77MCNY-13.18M · vs all stocks (USD)
Payout Ratio
0.00%Minority Interest (Equity)
137.13MCNYFY2025 · Dec 31, 2025Revenue
271.53MCNYFY2025 · Dec 31, 2025Cost of Goods Sold
214.75MCNYFY2025 · Dec 31, 2025Gross Profit
56.79MCNYFY2025 · Dec 31, 2025Operating Income
-5.99MCNY-889.06K · vs all stocks (USD)
Pre-tax Income
-5.37MCNYFY2025 · Dec 31, 2025Income Tax Expense
-1.38MCNYFY2025 · Dec 31, 2025Net Income
-3.99MCNYFY2025 · Dec 31, 2025EBIT
-5.36MCNYFY2025 · Dec 31, 2025EBITDA (Income Statement)
20.40MCNYFY2025 · Dec 31, 2025Research & Development
10.83MCNYFY2025 · Dec 31, 2025Selling, General & Administrative
23.50MCNYFY2025 · Dec 31, 2025Other Operating Expenses
2.81MCNYFY2025 · Dec 31, 2025Non-operating Interest Income
9.97MCNYFY2025 · Dec 31, 2025Non-operating Interest Expense
9.16KCNYFY2025 · Dec 31, 2025EPS (Basic)
-0.0030CNYFY2025 · Dec 31, 2025EPS (Diluted)
-0.0030CNYFY2025 · Dec 31, 2025Basic Shares Outstanding
1.46BSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
1.46BSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
-3.99MCNYFY2025 · Dec 31, 2025Minority Interests (P&L)
-394.32KCNYFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025Operating Cash Flow
-14.65MCNYFY2025 · Dec 31, 2025Free Cash Flow
-24.40MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
481.66MCNYFY2025 · Dec 31, 2025Starting Profit (CF Statement)
-3.99MCNYFY2025 · Dec 31, 2025Other Non-cash Items
111.97KCNYFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
21.02MCNYFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
-31.79MCNYFY2025 · Dec 31, 2025Capital Expenditures
-9.75MCNYFY2025 · Dec 31, 2025Purchase of Investments
-130.00MCNYFY2025 · Dec 31, 2025Sale of Investments
90.28MCNYFY2025 · Dec 31, 2025Net Investing Cash Flow
-49.48MCNYFY2025 · Dec 31, 2025Long-term Debt Issuance
787.50KCNYFY2025 · Dec 31, 2025Long-term Debt Payments
-2.00MCNYFY2025 · Dec 31, 2025Common Dividends Paid
-8.30KCNYFY2025 · Dec 31, 2025Other Financing Charges
-26.58KCNYFY2025 · Dec 31, 2025Net Financing Cash Flow
-1.25MCNYFY2025 · Dec 31, 2025Shares Outstanding
1.29BSharesUpdated Aug 19, 2026Float Shares
894.26MSharesUpdated Aug 19, 2026% Held by Insiders
32.69%vs all stocks
% Held by Institutions
0.22%vs all stocks
Total Cash (MRQ)
500.99MCNY74.41M · vs all stocks (USD)
Total Cash per Share (MRQ)
0.3890CNYUpdated Aug 19, 2026Total Debt (MRQ)
0.00CNYvs all stocks (USD)
Total Debt to Equity (MRQ)
0.00xCurrent Ratio (MRQ)
6.71xBook Value per Share (MRQ)
0.5260CNYUpdated Aug 19, 2026Total Assets
984.18MCNY146.17M · vs all stocks (USD)
Total Current Assets
788.37MCNYFY2025 · Dec 31, 2025Total Liabilities
165.02MCNYFY2025 · Dec 31, 2025Total Non-current Assets
195.81MCNYFY2025 · Dec 31, 2025Total Non-current Liabilities
38.48MCNYFY2025 · Dec 31, 2025Total Current Liabilities
126.55MCNYFY2025 · Dec 31, 2025Cash
481.66MCNYFY2025 · Dec 31, 2025Cash Equivalents
23.21MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents
504.87MCNYFY2025 · Dec 31, 2025Accounts Receivable
46.41MCNYFY2025 · Dec 31, 2025Inventory
170.58MCNYFY2025 · Dec 31, 2025Accounts Payable
112.02MCNYFY2025 · Dec 31, 2025Short-term Debt
787.50KCNYFY2025 · Dec 31, 2025Other Current Liabilities
138.79KCNYFY2025 · Dec 31, 2025Other Non-current Liabilities
36.51MCNYFY2025 · Dec 31, 2025Common Stock (Book)
1.29BCNYFY2025 · Dec 31, 2025Retained Earnings
-1.21BCNYFY2025 · Dec 31, 2025Total Shareholders' Equity
819.16MCNY121.66M · vs all stocks (USD)
52-Week Low
2.52CNYUpdated Aug 19, 202652-Week High
10.28CNYUpdated Aug 19, 202652-Week Change
-24.37%vs all stocks
Beta
0.4790xvs all stocks
50-Day MA
2.96CNYUpdated Aug 19, 2026200-Day MA
4.55CNYUpdated Aug 19, 2026Avg 10-Day Volume
36.38MSharesUpdated Aug 19, 2026Avg 30-Day Volume
49.50MSharesUpdated Aug 19, 2026Diluted EPS (TTM)
-0.0100CNYUpdated Aug 19, 20261 interpretation currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsWhere is this company structurally exposed?
Decline With Range Expansion And Drawdown
The price is falling, swinging wider than usual, and sits well below its peak.
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Structural Tensions
Valued far above the size of its businessSignificant
Price-to-Sales: 15.72Revenue Growth YoY: -0.24
Financial Health
Altman Z-Score 13.29: safe zoneNotable
Altman Z-Score: 13.29
Supply Chain
Midstream position: 5 outgoing, 4 incoming connectionsNotable
Outgoing: 5.00Incoming: 4.00
Companies that share the same coordination system — how they create, deliver, or capture value.
Hunan Hansen Pharmaceutical Co. Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Zeria Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Shanghai Aohua Photoelectricity Endoscope Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Prime Medicine Inc.
Tier 1ProductionApproval-Gated PipelineRule
4D Molecular Therapeutics, Inc.
Tier 1ProductionApproval-Gated PipelineRule
ChemoCentryx Inc
Tier 1ProductionApproval-Gated PipelineRule
Careray Digital Medical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Jiangsu Sihuan Bioengineering Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Wuhan Hiteck Biological Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Zhuhai Rundu Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Companies that share active interpretations — structural patterns currently present in both stocks.
Hunan Yujing Machinery Co., Ltd.
1 interpretationDecline With Range Expansion And Drawdown
Compass Therapeutics Inc.
1 interpretationDecline With Range Expansion And Drawdown
Zhejiang Hangke Technology Co., Ltd.
1 interpretationDecline With Range Expansion And Drawdown